Select Medical Buyout Faces Scrutiny Over $16.50 Per Share Price
Event summary
- Select Medical Holdings (NYSE: SEM) agreed to be acquired by an investment consortium for $16.50 per share in cash on March 2, 2026.
- Kaskela Law is investigating whether the buyout price is fair and whether fiduciary duties were breached.
- At least one analyst had a price target of $19.00 per share for Select Medical at the time of the announcement.
- Upon completion, Select Medical shares will no longer be publicly traded.
The big picture
The investigation into Select Medical's buyout highlights ongoing tensions between shareholder value and board decisions in healthcare M&A. With at least one analyst suggesting a higher valuation, the case could set a precedent for fair pricing in similar transactions. The outcome may influence how other companies approach shareholder compensation in future deals.
What we're watching
- Valuation Discrepancy
- How the $16.50 per share buyout price compares to analyst price targets and whether it reflects fair market value.
- Legal Challenges
- Whether Kaskela Law's investigation leads to legal action against Select Medical's officers or directors.
- Market Reaction
- The pace at which other shareholders join the investigation or seek additional compensation.
Related topics